Title
Date
MICURX COMPLETES $25 MILLION SERIES B FINANCING
2013.8.23
MICURX AND SHANGHAI ZHANGJIANG BIOMEDICAL INDUSTRY VENTURE CAPITAL PARTNER TO DEVELOP NEXT-GENERATION ANTIBIOTIC MRX-I FOR CHINESE MARKET
2012.10.26
MICURX PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT FOR ITS NEXT-GENERATION ANTIBACTERIAL AGENT
2012.6.29
MICURX PHARMACEUTICALS COMPLETES PHASE 1 TRIAL FOR MRX-I, A NEXT-GENERATION ANTIBIOTIC
2012.4.23
MICURX PHARMACEUTICALS AND CUMENCOR PHARMACEUTICALS PARTNER WITH PFIZER TO DISCOVER AND DEVELOP ANTIBIOTICS FOR DRUG-RESISTANT TUBERCULOSIS IN CHINA
2010.4.6
MICURX PHARMACEUTICALS FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR MRX-I
2010.3.15
MICURX PHARMACEUTICALS COMPLETES $10 MILLION SERIES A FINANCING TO FUND DISCOVERY AND DEVELOPMENT OF NEXT-GENERATION ANTIBIOTICS
2007.6.25
     
     
 
 
   
 
3916 Trust Way Hayward, CA 94545 USA     email: zyuan@micurx.com       Ph: (510) 782-2021
©MicuRx Pharmaceuticals, Inc. 2010. All rights reserved.